IO Biotech announced promising findings regarding a novel peptide vaccine designed to counter the immunosuppressive effects of Transforming Growth Factor Beta (TGF-β) in solid tumors. The research, ...
IO Biotech presents preclinical data supporting dual-antigen and TGF-β-targeted vaccines for enhancing anti-tumor immunity at AACR 2025. IO Biotech presented new preclinical data at the AACR Annual ...
Over the past few decades, the idea of modifying a patient’s own immune cells to recognize and destroy cancer has evolved from concept to reality. So-called “adoptive T cell therapy” has emerged as ...
Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...
AZoLifeSciences on MSN
How cancer cells physically adapt to survive within bodies
Cancer cells that detach from a primary tumor can remain hidden in the body for years in a dormant state, avoiding immune ...
New Memorial Sloan Kettering Cancer Center research reveals how dormant metastatic cancer cells protect themselves from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results